CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $2.1M of Cerevel Therapeutics Holdings, Inc.
Sold$2,105,125
$42.10Price
50,000Shares
−76%Stake
What CERE did after the filing
- The stock from Tue, May 14 close, $42.24
- −4.1%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Jun 27 close.
Traded Fri, May 10. Filed Tue, May 14, 1:16 PM ET, during the session. Returns use the May 14 close and the Jun 27 close. Not investment advice.